Global mRNA Vaccines & Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Page: 109

Published Date: 26 Jan 2021

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The mRNA Vaccines & Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global mRNA Vaccines & Therapeutics size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global mRNA Vaccines & Therapeutics market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
mRNA Vaccines & Therapeutics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Infectious Disease Vaccines
    Cancer Vaccines

Market segment by Application, can be divided into
    Infectious Disease
    Cancer

Market segment by players, this report covers
    Moderna Therapeutics
    CureVac
    Translate Bio
    BioNTech
    Sangamo Therapeutics
    Argos Therapeutics
    In-Cell-Art
    eTheRNA
    Ethris
    Tiba Biotechnology

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of mRNA Vaccines & Therapeutics
    1.2 Classification of mRNA Vaccines & Therapeutics by Type
        1.2.1 Overview: Global mRNA Vaccines & Therapeutics Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Type in 2020
        1.2.3 Infectious Disease Vaccines
        1.2.4 Cancer Vaccines
    1.3 Global mRNA Vaccines & Therapeutics Market by Application
        1.3.1 Overview: Global mRNA Vaccines & Therapeutics Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Infectious Disease
        1.3.3 Cancer
    1.4 Global mRNA Vaccines & Therapeutics Market Size & Forecast
    1.5 Global mRNA Vaccines & Therapeutics Market Size and Forecast by Region
        1.5.1 Global mRNA Vaccines & Therapeutics Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global mRNA Vaccines & Therapeutics Market Size by Region, (2016-2021)
        1.5.3 North America mRNA Vaccines & Therapeutics Market Size and Prospect (2016-2026)
        1.5.4 Europe mRNA Vaccines & Therapeutics Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific mRNA Vaccines & Therapeutics Market Size and Prospect (2016-2026)
        1.5.6 South America mRNA Vaccines & Therapeutics Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa mRNA Vaccines & Therapeutics Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 mRNA Vaccines & Therapeutics Market Drivers
        1.6.2 mRNA Vaccines & Therapeutics Market Restraints
        1.6.3 mRNA Vaccines & Therapeutics Trends Analysis

2 Company Profiles
    2.1 Moderna Therapeutics
        2.1.1 Moderna Therapeutics Details
        2.1.2 Moderna Therapeutics Major Business
        2.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Product and Solutions
        2.1.4 Moderna Therapeutics mRNA Vaccines & Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 Moderna Therapeutics Recent Developments and Future Plans
    2.2 CureVac
        2.2.1 CureVac Details
        2.2.2 CureVac Major Business
        2.2.3 CureVac mRNA Vaccines & Therapeutics Product and Solutions
        2.2.4 CureVac mRNA Vaccines & Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 CureVac Recent Developments and Future Plans
    2.3 Translate Bio
        2.3.1 Translate Bio Details
        2.3.2 Translate Bio Major Business
        2.3.3 Translate Bio mRNA Vaccines & Therapeutics Product and Solutions
        2.3.4 Translate Bio mRNA Vaccines & Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Translate Bio Recent Developments and Future Plans
    2.4 BioNTech
        2.4.1 BioNTech Details
        2.4.2 BioNTech Major Business
        2.4.3 BioNTech mRNA Vaccines & Therapeutics Product and Solutions
        2.4.4 BioNTech mRNA Vaccines & Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 BioNTech Recent Developments and Future Plans
    2.5 Sangamo Therapeutics
        2.5.1 Sangamo Therapeutics Details
        2.5.2 Sangamo Therapeutics Major Business
        2.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Product and Solutions
        2.5.4 Sangamo Therapeutics mRNA Vaccines & Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 Sangamo Therapeutics Recent Developments and Future Plans
    2.6 Argos Therapeutics
        2.6.1 Argos Therapeutics Details
        2.6.2 Argos Therapeutics Major Business
        2.6.3 Argos Therapeutics mRNA Vaccines & Therapeutics Product and Solutions
        2.6.4 Argos Therapeutics mRNA Vaccines & Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 Argos Therapeutics Recent Developments and Future Plans
    2.7 In-Cell-Art
        2.7.1 In-Cell-Art Details
        2.7.2 In-Cell-Art Major Business
        2.7.3 In-Cell-Art mRNA Vaccines & Therapeutics Product and Solutions
        2.7.4 In-Cell-Art mRNA Vaccines & Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 In-Cell-Art Recent Developments and Future Plans
    2.8 eTheRNA
        2.8.1 eTheRNA Details
        2.8.2 eTheRNA Major Business
        2.8.3 eTheRNA mRNA Vaccines & Therapeutics Product and Solutions
        2.8.4 eTheRNA mRNA Vaccines & Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 eTheRNA Recent Developments and Future Plans
    2.9 Ethris
        2.9.1 Ethris Details
        2.9.2 Ethris Major Business
        2.9.3 Ethris mRNA Vaccines & Therapeutics Product and Solutions
        2.9.4 Ethris mRNA Vaccines & Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 Ethris Recent Developments and Future Plans
    2.10 Tiba Biotechnology
        2.10.1 Tiba Biotechnology Details
        2.10.2 Tiba Biotechnology Major Business
        2.10.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Product and Solutions
        2.10.4 Tiba Biotechnology mRNA Vaccines & Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 Tiba Biotechnology Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global mRNA Vaccines & Therapeutics Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 mRNA Vaccines & Therapeutics Players Market Share
        3.2.2 Top 10 mRNA Vaccines & Therapeutics Players Market Share
        3.2.3 Market Competition Trend
    3.3 mRNA Vaccines & Therapeutics Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type
    4.1 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Type (2016-2021)
    4.2 Global mRNA Vaccines & Therapeutics Market Forecast by Type (2021-2026)

5 Market Size Segment by Application
    5.1 Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (2016-2021)
    5.2 mRNA Vaccines & Therapeutics Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application
    6.1 North America mRNA Vaccines & Therapeutics Revenue by Type (2016-2026)
    6.2 North America mRNA Vaccines & Therapeutics Revenue by Application (2016-2026)
    6.3 North America mRNA Vaccines & Therapeutics Market Size by Country
        6.3.1 North America mRNA Vaccines & Therapeutics Revenue by Country (2016-2026)
        6.3.2 United States mRNA Vaccines & Therapeutics Market Size and Forecast (2016-2026)
        6.3.3 Canada mRNA Vaccines & Therapeutics Market Size and Forecast (2016-2026)
        6.3.4 Mexico mRNA Vaccines & Therapeutics Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application
    7.1 Europe mRNA Vaccines & Therapeutics Revenue by Type (2016-2026)
    7.2 Europe mRNA Vaccines & Therapeutics Revenue by Application (2016-2026)
    7.3 Europe mRNA Vaccines & Therapeutics Market Size by Country
        7.3.1 Europe mRNA Vaccines & Therapeutics Revenue by Country (2016-2026)
        7.3.2 Germany mRNA Vaccines & Therapeutics Market Size and Forecast (2016-2026)
        7.3.3 France mRNA Vaccines & Therapeutics Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom mRNA Vaccines & Therapeutics Market Size and Forecast (2016-2026)
        7.3.5 Russia mRNA Vaccines & Therapeutics Market Size and Forecast (2016-2026)
        7.3.6 Italy mRNA Vaccines & Therapeutics Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific mRNA Vaccines & Therapeutics Revenue by Type (2016-2026)
    8.2 Asia-Pacific mRNA Vaccines & Therapeutics Revenue by Application (2016-2026)
    8.3 Asia-Pacific mRNA Vaccines & Therapeutics Market Size by Region
        8.3.1 Asia-Pacific mRNA Vaccines & Therapeutics Revenue by Region (2016-2026)
        8.3.2 China mRNA Vaccines & Therapeutics Market Size and Forecast (2016-2026)
        8.3.3 Japan mRNA Vaccines & Therapeutics Market Size and Forecast (2016-2026)
        8.3.4 South Korea mRNA Vaccines & Therapeutics Market Size and Forecast (2016-2026)
        8.3.5 India mRNA Vaccines & Therapeutics Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia mRNA Vaccines & Therapeutics Market Size and Forecast (2016-2026)
        8.3.7 Australia mRNA Vaccines & Therapeutics Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application
    9.1 South America mRNA Vaccines & Therapeutics Revenue by Type (2016-2026)
    9.2 South America mRNA Vaccines & Therapeutics Revenue by Application (2016-2026)
    9.3 South America mRNA Vaccines & Therapeutics Market Size by Country
        9.3.1 South America mRNA Vaccines & Therapeutics Revenue by Country (2016-2026)
        9.3.2 Brazil mRNA Vaccines & Therapeutics Market Size and Forecast (2016-2026)
        9.3.3 Argentina mRNA Vaccines & Therapeutics Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa mRNA Vaccines & Therapeutics Revenue by Type (2016-2026)
    10.2 Middle East & Africa mRNA Vaccines & Therapeutics Revenue by Application (2016-2026)
    10.3 Middle East & Africa mRNA Vaccines & Therapeutics Market Size by Country
        10.3.1 Middle East & Africa mRNA Vaccines & Therapeutics Revenue by Country (2016-2026)
        10.3.2 Turkey mRNA Vaccines & Therapeutics Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia mRNA Vaccines & Therapeutics Market Size and Forecast (2016-2026)
        10.3.4 UAE mRNA Vaccines & Therapeutics Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global mRNA Vaccines & Therapeutics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
    Table 2. Global mRNA Vaccines & Therapeutics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
    Table 3. Global Market mRNA Vaccines & Therapeutics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
    Table 4. Global mRNA Vaccines & Therapeutics Revenue (USD Million) by Region (2016-2021)
    Table 5. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region (2021-2026)
    Table 6. Moderna Therapeutics Corporate Information, Head Office, and Major Competitors
    Table 7. Moderna Therapeutics Major Business
    Table 8. Moderna Therapeutics mRNA Vaccines & Therapeutics Product and Solutions
    Table 9. Moderna Therapeutics mRNA Vaccines & Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 10. CureVac Corporate Information, Head Office, and Major Competitors
    Table 11. CureVac Major Business
    Table 12. CureVac mRNA Vaccines & Therapeutics Product and Solutions
    Table 13. CureVac mRNA Vaccines & Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 14. Translate Bio Corporate Information, Head Office, and Major Competitors
    Table 15. Translate Bio Major Business
    Table 16. Translate Bio mRNA Vaccines & Therapeutics Product and Solutions
    Table 17. Translate Bio mRNA Vaccines & Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 18. BioNTech Corporate Information, Head Office, and Major Competitors
    Table 19. BioNTech Major Business
    Table 20. BioNTech mRNA Vaccines & Therapeutics Product and Solutions
    Table 21. BioNTech mRNA Vaccines & Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 22. Sangamo Therapeutics Corporate Information, Head Office, and Major Competitors
    Table 23. Sangamo Therapeutics Major Business
    Table 24. Sangamo Therapeutics mRNA Vaccines & Therapeutics Product and Solutions
    Table 25. Sangamo Therapeutics mRNA Vaccines & Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 26. Argos Therapeutics Corporate Information, Head Office, and Major Competitors
    Table 27. Argos Therapeutics Major Business
    Table 28. Argos Therapeutics mRNA Vaccines & Therapeutics Product and Solutions
    Table 29. Argos Therapeutics mRNA Vaccines & Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 30. In-Cell-Art Corporate Information, Head Office, and Major Competitors
    Table 31. In-Cell-Art Major Business
    Table 32. In-Cell-Art mRNA Vaccines & Therapeutics Product and Solutions
    Table 33. In-Cell-Art mRNA Vaccines & Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 34. eTheRNA Corporate Information, Head Office, and Major Competitors
    Table 35. eTheRNA Major Business
    Table 36. eTheRNA mRNA Vaccines & Therapeutics Product and Solutions
    Table 37. eTheRNA mRNA Vaccines & Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 38. Ethris Corporate Information, Head Office, and Major Competitors
    Table 39. Ethris Major Business
    Table 40. Ethris mRNA Vaccines & Therapeutics Product and Solutions
    Table 41. Ethris mRNA Vaccines & Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 42. Tiba Biotechnology Corporate Information, Head Office, and Major Competitors
    Table 43. Tiba Biotechnology Major Business
    Table 44. Tiba Biotechnology mRNA Vaccines & Therapeutics Product and Solutions
    Table 45. Tiba Biotechnology mRNA Vaccines & Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 46. Global mRNA Vaccines & Therapeutics Revenue (USD Million) by Players (2019-2021)
    Table 47. Global mRNA Vaccines & Therapeutics Revenue Share by Players (2019-2021)
    Table 48. Breakdown of mRNA Vaccines & Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 49. mRNA Vaccines & Therapeutics Players Head Office, Products and Services Provided
    Table 50. mRNA Vaccines & Therapeutics Mergers & Acquisitions in the Past Five Years
    Table 51. mRNA Vaccines & Therapeutics New Entrants and Expansion Plans
    Table 52. Global mRNA Vaccines & Therapeutics Revenue (USD Million) by Type (2016-2021)
    Table 53. Global mRNA Vaccines & Therapeutics Revenue Share by Type (2016-2021)
    Table 54. Global mRNA Vaccines & Therapeutics Revenue Forecast by Type (2021-2026)
    Table 55. Global mRNA Vaccines & Therapeutics Revenue by Application (2016-2021)
    Table 56. Global mRNA Vaccines & Therapeutics Revenue Forecast by Application (2021-2026)
    Table 57. North America mRNA Vaccines & Therapeutics Revenue by Type (2016-2021) & (USD Million)
    Table 58. North America mRNA Vaccines & Therapeutics Revenue by Type (2021-2026) & (USD Million)
    Table 59. North America mRNA Vaccines & Therapeutics Revenue by Application (2016-2021) & (USD Million)
    Table 60. North America mRNA Vaccines & Therapeutics Revenue by Application (2021-2026) & (USD Million)
    Table 61. North America mRNA Vaccines & Therapeutics Revenue by Country (2016-2021) & (USD Million)
    Table 62. North America mRNA Vaccines & Therapeutics Revenue by Country (2021-2026) & (USD Million)
    Table 63. Europe mRNA Vaccines & Therapeutics Revenue by Type (2016-2021) & (USD Million)
    Table 64. Europe mRNA Vaccines & Therapeutics Revenue by Type (2021-2026) & (USD Million)
    Table 65. Europe mRNA Vaccines & Therapeutics Revenue by Application (2016-2021) & (USD Million)
    Table 66. Europe mRNA Vaccines & Therapeutics Revenue by Application (2021-2026) & (USD Million)
    Table 67. Europe mRNA Vaccines & Therapeutics Revenue by Country (2016-2021) & (USD Million)
    Table 68. Europe mRNA Vaccines & Therapeutics Revenue by Country (2021-2026) & (USD Million)
    Table 69. Asia-Pacific mRNA Vaccines & Therapeutics Revenue by Type (2016-2021) & (USD Million)
    Table 70. Asia-Pacific mRNA Vaccines & Therapeutics Revenue by Type (2021-2026) & (USD Million)
    Table 71. Asia-Pacific mRNA Vaccines & Therapeutics Revenue by Application (2016-2021) & (USD Million)
    Table 72. Asia-Pacific mRNA Vaccines & Therapeutics Revenue by Application (2021-2026) & (USD Million)
    Table 73. Asia-Pacific mRNA Vaccines & Therapeutics Revenue by Region (2016-2021) & (USD Million)
    Table 74. Asia-Pacific mRNA Vaccines & Therapeutics Revenue by Region (2021-2026) & (USD Million)
    Table 75. South America mRNA Vaccines & Therapeutics Revenue by Type (2016-2021) & (USD Million)
    Table 76. South America mRNA Vaccines & Therapeutics Revenue by Type (2021-2026) & (USD Million)
    Table 77. South America mRNA Vaccines & Therapeutics Revenue by Application (2016-2021) & (USD Million)
    Table 78. South America mRNA Vaccines & Therapeutics Revenue by Application (2021-2026) & (USD Million)
    Table 79. South America mRNA Vaccines & Therapeutics Revenue by Country (2016-2021) & (USD Million)
    Table 80. South America mRNA Vaccines & Therapeutics Revenue by Country (2021-2026) & (USD Million)
    Table 81. Middle East & Africa mRNA Vaccines & Therapeutics Revenue by Type (2016-2021) & (USD Million)
    Table 82. Middle East & Africa mRNA Vaccines & Therapeutics Revenue by Type (2021-2026) & (USD Million)
    Table 83. Middle East & Africa mRNA Vaccines & Therapeutics Revenue by Application (2016-2021) & (USD Million)
    Table 84. Middle East & Africa mRNA Vaccines & Therapeutics Revenue by Application (2021-2026) & (USD Million)
    Table 85. Middle East & Africa mRNA Vaccines & Therapeutics Revenue by Country (2016-2021) & (USD Million)
    Table 86. Middle East & Africa mRNA Vaccines & Therapeutics Revenue by Country (2021-2026) & (USD Million)
List of Figures
    Figure 1. mRNA Vaccines & Therapeutics Picture
    Figure 2. Global mRNA Vaccines & Therapeutics Revenue Market Share by Type in 2020
    Figure 3. Infectious Disease Vaccines
    Figure 4. Cancer Vaccines
    Figure 5. mRNA Vaccines & Therapeutics Revenue Market Share by Application in 2020
    Figure 6. Infectious Disease Picture
    Figure 7. Cancer Picture
    Figure 8. Global mRNA Vaccines & Therapeutics Revenue, (USD Million): 2020 VS 2021 VS 2026
    Figure 9. Global mRNA Vaccines & Therapeutics Revenue and Forecast (2016-2026) & (USD Million)
    Figure 10. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region (2016-2026)
    Figure 11. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region in 2020
    Figure 12. North America mRNA Vaccines & Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 13. Europe mRNA Vaccines & Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 14. Asia-Pacific mRNA Vaccines & Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 15. South America mRNA Vaccines & Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 16. Middle East and Africa mRNA Vaccines & Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 17. mRNA Vaccines & Therapeutics Market Drivers
    Figure 18. mRNA Vaccines & Therapeutics Market Restraints
    Figure 19. mRNA Vaccines & Therapeutics Market Trends
    Figure 20. Moderna Therapeutics Recent Developments and Future Plans
    Figure 21. CureVac Recent Developments and Future Plans
    Figure 22. Translate Bio Recent Developments and Future Plans
    Figure 23. BioNTech Recent Developments and Future Plans
    Figure 24. Sangamo Therapeutics Recent Developments and Future Plans
    Figure 25. Argos Therapeutics Recent Developments and Future Plans
    Figure 26. In-Cell-Art Recent Developments and Future Plans
    Figure 27. eTheRNA Recent Developments and Future Plans
    Figure 28. Ethris Recent Developments and Future Plans
    Figure 29. Tiba Biotechnology Recent Developments and Future Plans
    Figure 30. Global mRNA Vaccines & Therapeutics Revenue Share by Players in 2020
    Figure 31. mRNA Vaccines & Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    Figure 32. Global Top 3 Players mRNA Vaccines & Therapeutics Revenue Market Share in 2020
    Figure 33. Global Top 10 Players mRNA Vaccines & Therapeutics Revenue Market Share in 2020
    Figure 34. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
    Figure 35. Global mRNA Vaccines & Therapeutics Revenue Share by Type in 2020
    Figure 36. Global mRNA Vaccines & Therapeutics Market Share Forecast by Type (2021-2026)
    Figure 37. Global mRNA Vaccines & Therapeutics Revenue Share by Application in 2020
    Figure 38. Global mRNA Vaccines & Therapeutics Market Share Forecast by Application (2021-2026)
    Figure 39. North America mRNA Vaccines & Therapeutics Sales Market Share by Type (2016-2026)
    Figure 40. North America mRNA Vaccines & Therapeutics Sales Market Share by Application (2016-2026)
    Figure 41. North America mRNA Vaccines & Therapeutics Revenue Market Share by Country (2016-2026)
    Figure 42. United States mRNA Vaccines & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 43. Canada mRNA Vaccines & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 44. Mexico mRNA Vaccines & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 45. Europe mRNA Vaccines & Therapeutics Sales Market Share by Type (2016-2026)
    Figure 46. Europe mRNA Vaccines & Therapeutics Sales Market Share by Application (2016-2026)
    Figure 47. Europe mRNA Vaccines & Therapeutics Revenue Market Share by Country (2016-2026)
    Figure 48. Germany mRNA Vaccines & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 49. France mRNA Vaccines & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 50. United Kingdom mRNA Vaccines & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 51. Russia mRNA Vaccines & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 52. Italy mRNA Vaccines & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 53. Asia-Pacific mRNA Vaccines & Therapeutics Sales Market Share by Type (2016-2026)
    Figure 54. Asia-Pacific mRNA Vaccines & Therapeutics Sales Market Share by Application (2016-2026)
    Figure 55. Asia-Pacific mRNA Vaccines & Therapeutics Revenue Market Share by Region (2016-2026)
    Figure 56. China mRNA Vaccines & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 57. Japan mRNA Vaccines & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 58. South Korea mRNA Vaccines & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 59. India mRNA Vaccines & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 60. Southeast Asia mRNA Vaccines & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 61. Australia mRNA Vaccines & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 62. South America mRNA Vaccines & Therapeutics Sales Market Share by Type (2016-2026)
    Figure 63. South America mRNA Vaccines & Therapeutics Sales Market Share by Application (2016-2026)
    Figure 64. South America mRNA Vaccines & Therapeutics Revenue Market Share by Country (2016-2026)
    Figure 65. Brazil mRNA Vaccines & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 66. Argentina mRNA Vaccines & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 67. Middle East and Africa mRNA Vaccines & Therapeutics Sales Market Share by Type (2016-2026)
    Figure 68. Middle East and Africa mRNA Vaccines & Therapeutics Sales Market Share by Application (2016-2026)
    Figure 69. Middle East and Africa mRNA Vaccines & Therapeutics Revenue Market Share by Country (2016-2026)
    Figure 70. Turkey mRNA Vaccines & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 71. Saudi Arabia mRNA Vaccines & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 72. UAE mRNA Vaccines & Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 73. Methodology
    Figure 74. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology

Related Reports

Global mRNA Vaccines & Therapeutics Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Global mRNA Vaccines & Therapeutics Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

date 25 Nov 2021

date Pharma & Healthcare

The mRNA Vaccines & Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global mRNA Vaccines & Therapeutics Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global mRNA Vaccines & Therapeutics Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

date 04 Jan 2022

date Pharma & Healthcare

Product Tags

mrna vaccines therapeutics

mRNA Vaccines & Therapeutics

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>